GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CompuGroup Medical SE & Co KgaA (WBO:COP) » Definitions » 6-1 Month Momentum %

CompuGroup Medical SE KgaA (WBO:COP) 6-1 Month Momentum % : 58.74% (As of Mar. 28, 2025)


View and export this data going back to 2017. Start your Free Trial

What is CompuGroup Medical SE KgaA 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2025-03-28), CompuGroup Medical SE KgaA's 6-1 Month Momentum % is 58.74%.

The industry rank for CompuGroup Medical SE KgaA's 6-1 Month Momentum % or its related term are showing as below:

WBO:COP's 6-1 Month Momentum % is ranked better than
92.7% of 685 companies
in the Healthcare Providers & Services industry
Industry Median: -3.47 vs WBO:COP: 58.74

Competitive Comparison of CompuGroup Medical SE KgaA's 6-1 Month Momentum %

For the Health Information Services subindustry, CompuGroup Medical SE KgaA's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CompuGroup Medical SE KgaA's 6-1 Month Momentum % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CompuGroup Medical SE KgaA's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where CompuGroup Medical SE KgaA's 6-1 Month Momentum % falls into.


;
;

CompuGroup Medical SE KgaA  (WBO:COP) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CompuGroup Medical SE KgaA  (WBO:COP) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


CompuGroup Medical SE KgaA 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of CompuGroup Medical SE KgaA's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


CompuGroup Medical SE KgaA Business Description

Traded in Other Exchanges
Address
Maria Trost 21, Koblenz, DEU, 56070
CompuGroup Medical SE & Co KgaA provides electronic health solutions to healthcare providers through the following segments: Ambulatory information systems, Pharmacy information systems, and Hospital information systems. The Ambulatory information systems segment, which generates maximum revenue, focuses on developing and selling practice management software for registered physicians and medical care centers. This segment offers comprehensive end-to-end solutions that cover all essential clinical, administrative, and billing functions. In addition, its portfolio includes data-driven products, software interfaces for information exchange, medical decision support tools, and pharmaceutical and therapy databases, among other solutions. The company mainly operates in the U.S. and Europe.